Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Papamichail

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
Anticancer Research|July 23, 1998
The prognostic value of alpha-thymosins in breast cancerO E Tsitsilonis, E Bekris, I F Voutsas, et al.
Bulletin Du Cancer|August 10, 2001
[Recommendations on cancer screening in the European Union]M Micksche, E Lynge, V Diehl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2016
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrenceE A Mittendorf, A Ardavanis, J Symanowski, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
Anticancer Research|July 23, 1998
The prognostic value of alpha-thymosins in breast cancerO E Tsitsilonis, E Bekris, I F Voutsas, et al.
Bulletin Du Cancer|August 10, 2001
[Recommendations on cancer screening in the European Union]M Micksche, E Lynge, V Diehl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2016
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrenceE A Mittendorf, A Ardavanis, J Symanowski, et al.
Pageof 12